Sun Pharma announces settlement of patent litigation for generic Linzess in US
The Companies will grant, the wholly owned subsidiaries of Sun Pharma, a license to market a generic version of Linzess beginning…
Author
Post Feb 1, r-DNA derived drug applications to be accepted only online
Jan 15 CDSCO notice pertains to clinical trials, marketing authorisations, registration certificates and import licenses
Subodh Priolkar takes over as CEO, Wincoat Colours and Coatings
He has over three decades of experience in the pharma and associated industry
Patanjali ties up with 1mg to push online sales
The tie up will strategically increase online sales of Patanjali products; expand the reach to customers to end point
Novartis announces results from CLARITY study
Novartis new data reinforces superiority of Cosentyx versus Stelara in achieving skin clearance for psoriasis patients
PMB growing in Japan and Israel
Mergermarket, an Acuris company, has released full year 2017 Pharma, Medical & Biotech (PMB) report
Sanofi, Regeneron accelerate investment for clinical development
The companies collaborate for the clinical development of PD-1 antibody cemiplimab in oncology and dupilumab in Type 2 allergic…
FDD Leaders Handbook
FDD Leaders Handbook featured the leaders in formulation development and drug delivery who are helming India’s journey to become…
Lynparza approved by US FDA
Lynparza is the first and only PARP inhibitor approved for use beyond ovarian cancer